According to Intent Market Research, the Intensity Modulated Radiotherapy Market is expected to grow from USD 2.1 billion in 2023-e at a CAGR of 4.8% to touch USD 2.8 billion by 2030. The intensity modulated radiotherapy market is dominated by key players such as Elekta, Siemens Healthineers, Accuray Incorporated, Varian Medical Systems, Brainlab, Philips, and Hitachi.

Breast Lesion Localization Market was valued at USD 0.3 billion in 2023-e and will surpass USD 0.4 billion by 2030; growing at a CAGR of 6.1% during 2024 - 2030.

According to Intent Market Research, the Bone Cement & Glue Market is expected to grow from USD 1.6 billion in 2023-e at a CAGR of 6.0% to touch USD 2.3 billion by 2030. The Bone Cement & Glue Market is dominated by key players such as Stryker, Zimmer Biomet, Smith+Nephew, Medtronic, Cardinal Health, DePuy Synthes, and Enovis.

According to Intent Market Research, the Intraoral/ IOL Scanners Market is expected to grow from USD 0.6 billion in 2023-e at a CAGR of 10.6% to touch USD 1.1 billion by 2030. The Intraoral/ IOL scanners market is competitive; where the prominent players include DENTSPLY SIRONA, Align Technology, Envista, 3shape, Fussen, Launca, 3DISC, and Medit Corp.

According to Intent Market Research, the Blood Culture Tests Market is expected to grow from USD 4.9 billion in 2023-e at a CAGR of 7.5% to touch USD 8.2 billion by 2030. The Blood Culture Tests Market is dominated by key players such as Roche Diagnostics, Becton, Dickinson and Company, Biomérieux, Himedia Laboratories, Scenker Biological Technology, Thermo Fisher Scientific, and Danaher.

According to Intent Market Research, the Incontinence Care Products Market is expected to grow from USD 11.9 billion in 2023-e at a CAGR of 5.1% to touch USD 16.9 billion by 2030. The Incontinence Care Products Market is dominated by key players such as Essity Aktiebolag, Procter & Gamble, Kimberly-Clark, Hartmann, Unicharm, Ontex BV, amongst others

According to Intent Market Research, the Bioimpedance Analyzers Market is expected to grow from USD 0.5 billion in 2023-e at a CAGR of 9.7% to touch USD 1.0 billion by 2030. The Bioimpedance Analyzers Market is dominated by key players such as Tanita Corporation, InBody, EVOLT, OMRON Corporation, RJL Systems, and Seca GmbH.

According to Intent Market Research, the In Vitro Toxicology Testing Market is expected to grow from USD 10.3 billion in 2023-e at a CAGR of 9.0% to touch USD 18.9 billion by 2030. The In Vitro Toxicology Testing Market is dominated by key players such as Thermo Fisher Scientific, SGS, Merck, Eurofins Scientific, Intertek, Laboratory Corporation of America Holdings, Agilent, amongst others.

According to Intent Market Research, the Immunoassay Market is expected to grow from USD 33.3 billion in 2023-e at a CAGR of 5.4% to touch USD 48.2 billion by 2030. The Immunoassay Market is dominated by key players such as Abbott, Roche, Qiagen, Agilent, Thermo Fisher Scientific, Merck, Danaher, Siemens Healthineers, amongst others.

According to Intent Market Research, the Humanized Mouse and Rat Model Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 6.0% to touch USD 0.4 billion by 2030. The Humanized Mouse and Rat Model Market is competitive; where the prominent players include Charles River Laboratories, Taconic Biosciences, Crown Bioscience, Amgen, Champions Oncology, Hera BioLabs, among others.

According to Intent Market Research, the Cleanroom Technologies Market is expected to grow from USD 7.8 billion in 2023-e at a CAGR of 6.3% to touch USD 12.0 billion by 2030. The cleanroom technologies market is dominated by key players such as Dynarex, Colandis, ABN Cleanroom Technology, Clean Rooms International, Kimberly-Clark, DuPont, and Illinois Tool Works.

According to Intent Market Research, the Cellulose Ether & Derivatives Market is expected to grow from USD 7.7 billion in 2023-e at a CAGR of 8.6% to touch USD 13.7 billion by 2030. The cellulose ether & derivatives market is dominated by key players such as Dow, Ashland, Fenchem, Shandong Head, Rayonier Advanced Materials, Shin-Etsu Chemical, LOTTE Fine Chemicals, and DKS Co. Ltd.

According to Intent Market Research, the Cell Culture Media Market is expected to grow from USD 5.9 billion in 2023-e at a CAGR of 15.5% to touch USD 16.1 billion by 2030. The cell culture media market is dominated by key players such as Thermo Fisher Scientific, Merck KGaA, Corning Incorporated, Becton & Dickinson, FUJIFILM Irvine Scientific, and Danaher Corporation.

HLA Typing for Transplant Market By Technology (Non-molecular, Molecular), By Transplant Type (Soft Tissue, Solid Organ), By Product & Service (Instruments, Reagents & Consumables, Software & Services) By End Use (Hospitals and Clinics, Research Laboratories) and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cell Analysis Market is expected to grow from USD 19.2 billion in 2023-e at a CAGR of 10.4% to touch USD 38.4 billion by 2030. The cell analysis market is dominated by key players such Agilent Technologies, Bio-Rad, Illumina, Thermo Fisher Scientific, PerkinElmer, Becton & Dickinson, Standard Biotools, amongst others.

According to Intent Market Research, the Hemostats Market is expected to grow from USD 2.5 billion in 2023-e at a CAGR of 6.2%to touch USD 3.9 billion by 2030. The Hemostats Market is dominated by key players such as Johnson & Johnson, Baxter, Becton & Dickinson, Pfizer, B. Braun, Medtronic, Stryker, among others.

According to Intent Market Research, the Cell Therapy Technologies Market is expected to grow from USD 4.0 billion in 2023-e at a CAGR of 12.8% to touch USD 9.2 billion by 2030. The cell therapy technologies market is dominated by key players such as Thermo Fisher Scientific, Merck, Danaher, Terumo, Becton & Dickinson, Lonza, amongst others.

According to Intent Market Research, the Glycated Albumin Assay Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 8.6% to touch USD 0.3 billion by 2030. The Glycated Albumin Assay Market is competitive; where the prominent players include Asahi Kasei, PerkinElmer, Tecan Lifesciences, Agilent, Beijing Strong Biotechnologies, Diazyme Laboratories, DxGen Corp., Weldon Biotech, among others.

According to Intent Market Research, the Animal Genetics Market is expected to grow from USD 6.3 billion in 2023-e at a CAGR of 6.9% to touch USD 10.1 billion by 2030. The animal genetics market is dominated by key players such as Neogen Corporation, Genus, Urus, EW Group, Groupe Grimaud, Topigs Norsvin, CRV Holding, amongst others.

According to Intent Market Research, the AI in Pathology Market is expected to grow from USD 0.01 billion in 2023-e at a CAGR of 14.6% to touch USD 0.1 billion by 2030. The AI in pathology market is dominated by key players such as Koninklijke Philips, Tribun Health, Lumea, Hoffmann-La Roche Ltd, and Hologic.

According to Intent Market Research, the Blood Group Typing Market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 8.2% to touch USD 3.3 billion by 2030. The blood group typing market is dominated by key players such as Bio-Rad Laboratories, Grifols, QuidelOrtho Corporation, Merck, Quotient, Danaher, Thermo Fisher Scientific, and Immucor.

According to Intent Market Research, the Flow Cytometry Market is expected to grow from USD 4.5 billion in 2023-e at a CAGR of 7.8% to touch USD 7.5 billion by 2030. The Flow Cytometry Market is dominated by key players such as Danaher, Thermo Fisher Scientific, Agilent, bioMérieux, Bio-Rad Laboratories, Becton & Dickinson, among others.

According to Intent Market Research, the Gene Editing Market is expected to grow from USD 5.0 billion in 2023-e at a CAGR of 14.5% to touch USD 12.9 billion by 2030. The Gene Editing Market is competitive; where the prominent players include Merck, Thermo Fisher Scientific, GenScript, Tecan Life Sciences, Agilent, Lonza, PerkinElmer, among others.

According to Intent Market Research, the Adhesion Barrier Market is expected to grow from USD 0.6 billion in 2023-e at a CAGR of 6.9% to touch USD 1.0 billion by 2030. The adhesion barrier market is dominated by key players such as Johnson & Johnson, Becton & Dickinson, Integra LifeSciences, Baxter, Bioscompass, Atrium Medical, Anika Therapeutics, MAST Biosurgery, amongst others.

According to Intent Market Research, the Biotechnology Contract Manufacturing Market is expected to grow from USD 15.8 billion in 2023-e at a CAGR of 7.8% to touch USD 26.8 billion by 2030. The biotechnology contract manufacturing market is dominated by key players such as Catalent, Samsung Biologics, Fujifilm Holdings, Eurofins Scientific, Thermo Fisher Scientific, Lonza, Merck and WuXi Biologics.

According to Intent Market Research, the Biopsy Devices Market is expected to grow from USD 6.2 billion in 2023-e at a CAGR of 13.5% to touch USD 15.1 billion by 2030. The biopsy devices market is dominated by key players such as Becton & Dickinson, Cook Group Incorporated, Hologic, B. Braun, Stryker, Devicor Medical Products, and Olympus Corporation.

According to Intent Market Research, the Ventilators Market is expected to grow from USD 4.8 billion in 2023-e at a CAGR of 7.5% to touch USD 7.9 billion by 2030. The ventilators market is competitive, the prominent players in the global market include ABM Respiratory Care, Airon, Baxter International, Bio-Medical Electronics, Drägerwerk, GE Healthcare, Getinge AB, Hamilton Medical, ICU Medical, Philips, Medtronic, Metran, Shenzhen Mindray, and Vyaire Medical.

According to Intent Market Research, the AI in Medical Diagnostics Market is expected to grow from USD 1.2 billion in 2023-e at a CAGR of 22.6% to touch USD 5.2 billion by 2030. The AI in Medical Diagnostics market is dominated by key players such as Microsoft, Alphabet, NVIDIA Corporation, Merative, GE Healthcare, Digital Diagnostics, Siemens Healthineers, Philips, amongst others.

According to Intent Market Research, the Robotic Dentistry Market is expected to grow from USD 410 million in 2023-e at a CAGR of 18.3% to touch USD 1,329.5 million by 2030. The robotic dentistry market is competitive, the prominent players in the global market include 3Shape, Align Technology, Beijing Baihui Weikang Technology, Dentsply Sirona, Envista Holdings, Intutuive Surgical, Image Navigation, Neocis, Planmeca, and Zimmer Biomet.

According to Intent Market Research, the RNA Analysis Market is expected to grow from USD 5.5 billion in 2023-e at a CAGR of 10.8% to touch USD 10.3 billion by 2030. The RNA analysis market is competitive, the prominent players in the global market include Agilent, Basepair, BioMérieux, Bio-Rad Laboratories, Eurofins, GenXPro, Illumina, Promega Corporation, Qiagen, Roche, Thermo Fisher Scientific, amongst others.

According to Intent Market Research, the Precision Medicine Market is expected to grow from USD 30.7 billion in 2023-e at a CAGR of 11.4% to touch USD 59.3 billion by 2030. The precision medicine market is competitive, the prominent players in the global market include AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Catalent, Eli Lilly, Gilead Sciences, Johnson & Johnson, Lonza, Merck, Novartis, Parexel, Pfizer, Roche, Sanofi, Takeda Pharmaceutical, amongst others.

The Plasma Fractionation Market is expected to grow from USD 31.7 billion in 2023-e to USD 50.1 billion by 2030, at a CAGR of 7.8%.

The microfluidics market is expected to grow from USD 23.1 billion in 2023-e to USD 51.0 billion by 2030, at a CAGR of 14.0% during the forecast period. The microfluidics market is a competitive market, the prominent players in the global market include Agilent Technologies, Beckton Dickinson and Company, Biomérieux, Bio-Rad, Danaher Corporation, Fluidigm Corporation, Hologic, Illumina, PerkinElmer, Roche, Thermo Fisher Scientific.

According to Intent Market Research, the Continuous Renal Replacement Therapy (CRRT) Market is expected to grow from USD 1.5 billion in 2023-e at a CAGR of 7.8% to touch USD 2.0 billion by 2030. The CRRT market is competitive, the prominent players in the global market include Asahi Kasei Medical, B. Braun, Baxter International, Cytosorbents, Fresenius Medical Care, Infomed SA, Medtronic, Nikkiso, NIPRO, Toray Medical.

According to Intent Market Research, the clinical decision support systems market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 8.1% to touch USD 3.1 billion by 2030. The clinical decision support systems market is competitive, the prominent players in the global market include 3M Health Information Systems, Allscripts, Cerner Corporation, Change Healthcare, Elsevier BV, Epic Systems, GE Healthcare, IBM Watson Health, McKesson Corporation, Meditech, NextGen Healthcare, Oracle, Philips Healthcare, Siemens Healthineers, and Wolters Kluwer Health.

According to Intent Market Research, the Cardiac Marker Testing Market is expected to grow from USD 4.8 billion in 2023-e at a CAGR of 10.3% to touch USD 9.7 billion by 2030. The cardiac marker testing is a competitive market, the prominent players in the global market include Abbott, BD, bioMérieux, Bio-Rad, Danaher, DiaSorin, LSI Medience, PerkinElmer, Quidel, Roche, Siemens, Thermo Fisher Scientific, and Tosoh.

According to Intent Market Research, the Biofabrication Market is expected to grow from USD 21.0 billion in 2023-e at a CAGR of 7.3% to touch USD 34.8 billion by 2030. Prominent players include Allevi, Cellink Global, Cyfuse Biomedical, Danaher, Envisiontec, Eppendorf, Inventia Life Science, Merck, Organovo Holdings, Poietis, Regemat 3D, Sartorius Stedim Biotech, Thermo Fisher Scientific, Vivax Bio and 3D Bioprinting Solutions.

According to Intent Market Research, the AI in Drug Discovery Market is expected to grow from USD 850 million in 2023-e at a CAGR of 40.5% to touch USD 4,500 million by 2030. The AI in drug discovery market is a competitive market, the prominent players in the global market include BenevolentAI, BioXcel Therapeutics, Deep Genomics, Exscientia, Google, Insilico Medicine, IQVIA, Labcorp, Microsoft, NVIDIA, and Recursion.

According to Intent Market Research, the Medical Device Validation and Verification Market is expected to grow from USD 10.8 billion in 2023-e at a CAGR of 4.7% to touch USD 14.8 billion by 2030. The medical device validation and verification is a competitive market, the prominent players in the global market include BSI Group, Bureau Veritas, Charles River, DekraTesting and Certification, Element Materials Technology. Eurofins Scientific, Intertek Group, Pace Analytical Services, Quest Global, SGS, Sterling Medical Devices, TUV Rheinland, WuXi AppTe.

The laboratory proficiency testing market is expected to grow from USD 1.3 billion in 2023-e to USD 2.1 billion by 2030, at a CAGR of 6.8% during the forecast period. The laboratory proficiency testing is a competitive market, the prominent players in the global market include American Proficiency Institute, AOAC International, Bio-Rad, BIPEA, College of American Pathologists, Fapas, INSTAND, LGC, Merck, NSI Lab Solutions, QACS, Randox, Trilogy, Waters, and Weqas.

The Image-guided Radiation Therapy (IGRT) market is expected to grow from USD 1.7 billion in 2023-e to USD 2.4 billion by 2030, at a CAGR of 5.3% during the forecast period. The IGRT is a competitive market, the prominent players in the global market include Accuray, Canon, C-Rad, Elekta, GE Healthcare, GenesisCare, Mevion, Philips, RefleXion, Siemens, Sun Nuclear, ViewRay, and Vision RT.

The clinical trial supplies market is expected to grow from USD 4.3 billion in 2023-e to USD 8.7 billion by 2030, at a CAGR of 10.2% during the forecast period. The clinical trial supplies market is a competitive market, the prominent players in the global market include Almac Group, Biocair, Catalent, Eurofins Scientific, Nuvisan, Lonza Group, PCI Pharma Services, Piramal Pharma Solutions, PRA Health Sciences, Sharp Services, and Thermo Fisher Scientific.

The breast biopsy devices market is expected to grow from USD 1.8 billion in 2023-e to USD 3.4 billion by 2030, at a CAGR of 9.7% during the forecast period. The breast biopsy devices market is a competitive market, the prominent players in the global market include Argon Medical Devices, Becton Dickinson and Company, Cook Medical, Devicor Medical Products, F. Hoffmann-La Roche, GE Healthcare, Hologic, Leica Biosystems, Medax Srl, Planmed, Scion Medical Technologies, and Siemens Healthier.

The biomarkers market is expected to grow from USD 79.3 billion in 2023-e to USD 187.4 billion by 2030, at a CAGR of 14.7% during the forecast period. The biomarkers market is dominated by key players such as Amgen, Biogen, Biognosys, Bio-rad, Chordia Therapeutics, Epigenomics, Evotec, Koneksa, Myriad Genetics, Quanterix, Sengenics, Siemens, Thermo Fisher Scientific, and Veravas.

The acquisition of smaller players and product innovations by major players are driving the AI in cell and gene therapy market. The AI in cell and gene therapy market is a competitive market, the prominent players in the global market include Dyno Therapeutics, Exelixis, Form Bio, Généthon, DeepMind (Google), IBM, Insilico, Microsoft, Nosis Bio, Oxford BioMedica, SK Pharmteco, Thales